MedTrace Logo

Effects of Wobenzym® Plus in Healthy, Sportive People After Eccentric Exercise

NCT01845558 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2015-08-28

No results posted yet for this study

Summary

The aim of the current study is to investigate the therapeutic effect and especially the mode of action of Wobenzym® plus, an anti-inflammatory drug containing proteolytic enzymes, on exercise induced muscle damage (eiMD) and recovery time in male amateur sportsmen with medium proficiency level compared to placebo.

Conditions

  • Muscle Injury
  • Muscle Soreness
  • Exercise Induced Muscle Damage

Interventions

DRUG

Wobenzym® plus

OTHER

Placebo

Sponsors & Collaborators

  • Mucos Pharma GmbH & Co. KG

    lead INDUSTRY

Principal Investigators

  • Helmut Pabst, Dr. med · PWC GmbH

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01845558 on ClinicalTrials.gov